Published in Blood Transfus on December 13, 2012
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care (2016) 1.43
Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care (2013) 1.00
Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution. J Trauma Acute Care Surg (2014) 0.85
Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med (2013) 0.81
In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor. Blood Transfus (2013) 0.80
Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®). Scand J Clin Lab Invest (2015) 0.80
Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma. Scand J Trauma Resusc Emerg Med (2015) 0.77
Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM. Scand J Trauma Resusc Emerg Med (2014) 0.77
Thromboelastometric and platelet responses to silk biomaterials. Sci Rep (2014) 0.75
Preferential effects of low volume versus high volume replacement with crystalloid fluid in a hemorrhagic shock model in pigs. BMC Anesthesiol (2015) 0.75
Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery. Perioper Med (Lond) (2015) 0.75
Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet (2001) 3.24
Management of bleeding following major trauma: an updated European guideline. Crit Care (2010) 3.09
Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg (2007) 2.68
Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med (1999) 2.67
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care (2010) 2.47
Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg (2012) 2.36
Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth (1997) 2.27
Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth (2010) 2.01
Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg (2011) 1.77
Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg (2006) 1.68
Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med (2011) 1.66
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care (2011) 1.66
In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost (2010) 1.63
Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand (2005) 1.61
Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia (2007) 1.57
FIBTEM provides early prediction of massive transfusion in trauma. Crit Care (2011) 1.48
Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg (2011) 1.46
Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med (2012) 1.46
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus (2011) 1.45
Effects of combined balanced colloid and crystalloid on rotational thromboelastometry in vitro. Perfusion (2011) 1.45
Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand (2009) 1.42
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost (2009) 1.36
Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg (2003) 1.18
Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus (2011) 1.17
Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand (2011) 1.09
The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg (2006) 1.08
Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis (1995) 1.06
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke (2002) 1.06
F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol (2010) 0.98
Factor XIII--an under diagnosed deficiency--are we using the right assays? J Thromb Haemost (2010) 0.98
Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma (2011) 0.97
The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg (2008) 0.92
Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand (2005) 0.92
Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis (2004) 0.92
The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg (2004) 0.91
Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth (2010) 0.87
Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg (2006) 0.85
Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand (1998) 0.83
[Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients]. Hamostaseologie (2010) 0.81
Intraoperative blood salvage: fluid replacement calculations. Anesth Analg (2005) 0.79
Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth (2011) 0.78
Temporal changes in ROTEM®-measured coagulability of citrated blood samples from coagulopathic trauma patients. Injury (2011) 0.78
The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagul Fibrinolysis (2004) 0.77